Our TactiCath™ family of contact force ablation catheters includes two catheters — the TactiCath™ Quartz Contact Force Ablation Catheter and the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ — that are innovative solutions for the treatment of atrial fibrillation (AF).
The TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ - our next generation of technology. Discover a contact force catheter uniquely designed for effortless handling performance.1*
The TactiCath™ Quartz Contact Force Ablation Catheter is the pioneer in Abbott contact force (CF) technology that provides proven greater accuracy in head-to-head comparison to competitive CF sensing catheters.2,3**
Our next generation of technology — the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™— includes a handle and shaft combination that offers maneuverability along with comfort and ease of use.1 It is fully integrated4,5 with the Ensite Precision™ Cardiac Mapping System, creating a seamless workflow within the lab.
TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ Animation
Watch this short animation that explores how the contact force sensing of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ works.
The TactiCath™ family of catheters is built on interferometry technology:
*Effortless handling is based on how physicians scored catheter handling characteristics during an initial market release.
**In an independent head-to-head bench test comparison with the ThermoCool SmartTouch‡ SF catheter, TactiCath™ Quartz Contact Force Ablation Catheter showed higher accuracy in both axial (perpendicular) and parallel (lateral) orientations.3
The primary effectiveness endpoint result was 67.8% and was defined as no documented, symptomatic recurrence of atrial arrhythmia > 30 s (of all AADs after three-month blanking).
1. Abbott. Data on File. LMR Memo #90349982.
2. Bourier, F., Gianni, C., Dare, M., Deisenhofer, I., Hessling, G., Reents, T., . . . Al-Ahmad, A. (2017). Fiberoptic contact-force sensing electrophysiological catheters: how precise is the technology? Journal of Cardiovascular Electrophysiology, 28(1), 109-114.
3. Bourier F, Deisenofer I, Hessling G, et al. Contact-force sensing electrophysiological catheters: How accurate is the technology? [Abstract PO03-170]. Presentation at HRS 2016, San Francisco, CA, May 4-7, 2016. Heart Rhythm. 2016;13(5 Suppl 1):S318-S319.
4. Abbott. Data on file. Report 90214738
5. Abbott. Data on File. Report 90253949
This product is intended for use by or under the direction of a physician. Prior to use, reference Instructions for Use, inside the product carton (when available) or at manuals.sjm.com or eifu.abbottvascular.com for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Indications: The TactiCath™ Quartz Contact Force Ablation Catheter and TactiCath™ Ablation Catheter, Sensor Enabled™ are indicated for use in cardiac electrophysiological mapping and for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used in conjunction with a compatible RF generator and three-dimensional mapping system.
Contraindications: Do not use for any of the following conditions: certain recent heart surgery; prosthetic valves; active systemic infection; use in coronary vasculature; myxoma or intracardiac thrombus, or an interatrial baffle or patch; retrograde trans-aortic approach in patients with aortic valve replacement.
Warnings: It is important to carefully titrate RF power; too high RF power during ablation may lead to perforation caused by steam pop. Contact force in excess of 70 g may not improve the characteristics of lesion formation and may increase the risk for perforation during manipulation of the catheter. Patients undergoing septal accessory pathway ablation are at risk for complete AV block which requires the implantation of a permanent pacemaker. Implantable pacemakers and implantable cardioverter/defibrillator may be adversely affected by RF current. Always verify the tubing and catheter have been properly cleared of air prior to inserting the catheter into the vasculature since entrapped air can cause potential injury or fatality. The temperature data transmitted by the sensor in this catheter is representative of the irrigated electrode only and does not provide tissue temperature data.
Precautions: The long-term risks of protracted fluoroscopy and creation of RF induced lesions have not been established; careful consideration must be given for the use of the device in prepubescent children. When using the catheter with conventional EP lab system or with a 3-D navigational system, careful catheter manipulation must be performed, in order to avoid cardiac damage, perforation, or tamponade. Always maintain a constant saline irrigation flow to prevent coagulation within the lumen of the catheter. Care should be taken when ablating near structures such as the sino-atrial and AV nodes.
Potential Adverse Events: Potential adverse events include, but are not limited to, cardiovascular related complications, including groin hematoma, pericardial effusion and infection. More serious complications are rare, which can include damage to the heart or blood vessels; blood clots (which may lead to stroke); tamponade; severe pulmonary vein stenosis; heart attack; esophageal fistula, or death.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.